[Federal Register Volume 75, Number 236 (Thursday, December 9, 2010)]
[Notices]
[Page 76756]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-30904]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 19, 2010, and published in the Federal 
Register on July 28, 2010, (75 FR 44285), Johnson Matthey 
Pharmaceutical Materials, Inc., Pharmaceuticals Service, 25 Patton 
Road, Devens, Massachusetts 01434, made application by letter to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Nabilone (7379)............................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Remifentanil (9739)........................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk and to conduct 
analytical testing in support of the company's primary manufacturing 
facility in West Deptford, New Jersey. The controlled substances 
manufactured in bulk at this facility will be distributed to the 
company's customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the 
listed basic classes of controlled substances is consistent with the 
public interest at this time. DEA has investigated Johnson Matthey 
Pharmaceutical Materials, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, 
the above named company is granted registration as a bulk manufacturer 
of the basic classes of controlled substances listed.

    Dated: November 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-30904 Filed 12-8-10; 8:45 am]
BILLING CODE 4410-09-P